Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2023

Open Access 01-12-2023 | Obesity | Research

BMI-based obesity classification misses children and adolescents with raised cardiometabolic risk due to increased adiposity

Authors: J. Karina Zapata, M. Cristina Azcona-Sanjulian, Victoria Catalán, Beatriz Ramírez, Camilo Silva, Amaia Rodríguez, Javier Escalada, Gema Frühbeck, Javier Gómez-Ambrosi

Published in: Cardiovascular Diabetology | Issue 1/2023

Login to get access

Abstract

Objective

To assess how inaccurately the body mass index (BMI) is used to diagnose obesity compared to body fat percentage (BF%) measurement and to compare the cardiometabolic risk in children and adolescents with or without obesity according to BMI but with a similar BF%.

Methods

A retrospective cross-sectional investigation was conducted including 553 (378 females/175 males) white children and adolescents aged 6–17 years, 197 with normal weight (NW), 144 with overweight (OW) and 212 with obesity (OB) according to BMI. In addition to BMI, BF% measured by air displacement plethysmography, as well as markers of cardiometabolic risk had been determined in the existing cohort.

Results

We found that 7% of subjects considered as NW and 62% of children and adolescents classified as OW according to BMI presented a BF% within the obesity range. Children and adolescents without obesity by the BMI criterion but with obesity by BF% exhibited higher blood pressure and C-reactive protein (CRP) in boys, and higher blood pressure, glucose, uric acid, CRP and white blood cells count, as well as reduced HDL-cholesterol, in girls, similar to those with obesity by BMI and BF%. Importantly, both groups of subjects with obesity by BF% showed a similarly altered glucose homeostasis after an OGTT as compared to their NW counterparts.

Conclusions

Results from the present study suggest increased cardiometabolic risk factors in children and adolescents without obesity according to BMI but with obesity based on BF%. Being aware of the difficulty in determining body composition in everyday clinical practice, our data show that its inclusion could yield clinically useful information both for the diagnosis and treatment of overweight and obesity.
Appendix
Available only for authorised users
Literature
1.
go back to reference Catalán V, Avilés-Olmos I, Rodríguez A, Becerril S, Fernández-Formoso JA, Kiortsis D, Portincasa P, Gómez-Ambrosi J, Frühbeck G. Time to consider the Exposome hypothesis in the development of the obesity pandemic. Nutrients. 2022;14:1597.PubMedPubMedCentral Catalán V, Avilés-Olmos I, Rodríguez A, Becerril S, Fernández-Formoso JA, Kiortsis D, Portincasa P, Gómez-Ambrosi J, Frühbeck G. Time to consider the Exposome hypothesis in the development of the obesity pandemic. Nutrients. 2022;14:1597.PubMedPubMedCentral
2.
go back to reference Collaboration NRF. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390:2627–42. Collaboration NRF. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390:2627–42.
3.
go back to reference Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the global burden of Disease Study 2013. Lancet. 2014;384:766–81.PubMedPubMedCentral Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the global burden of Disease Study 2013. Lancet. 2014;384:766–81.PubMedPubMedCentral
4.
go back to reference Yárnoz-Esquiroz P, Olazarán L, Aguas-Ayesa M, Perdomo CM, García-Goni M, Silva C, Fernández-Formoso JA, Escalada J, Montecucco F, Portincasa P, et al. Obesities’: position statement on a complex disease entity with multifaceted drivers. Eur J Clin Invest. 2022;52:e13811.PubMedPubMedCentral Yárnoz-Esquiroz P, Olazarán L, Aguas-Ayesa M, Perdomo CM, García-Goni M, Silva C, Fernández-Formoso JA, Escalada J, Montecucco F, Portincasa P, et al. Obesities’: position statement on a complex disease entity with multifaceted drivers. Eur J Clin Invest. 2022;52:e13811.PubMedPubMedCentral
5.
go back to reference Perdomo CM, Cohen RV, Sumithran P, Clement K, Frühbeck G. Contemporary medical, device, and surgical therapies for obesity in adults. Lancet. 2023;401:1116–30.PubMed Perdomo CM, Cohen RV, Sumithran P, Clement K, Frühbeck G. Contemporary medical, device, and surgical therapies for obesity in adults. Lancet. 2023;401:1116–30.PubMed
6.
go back to reference Skinner AC, Perrin EM, Moss LA, Skelton JA. Cardiometabolic risks and severity of obesity in children and young adults. N Engl J Med. 2015;373:1307–17.PubMed Skinner AC, Perrin EM, Moss LA, Skelton JA. Cardiometabolic risks and severity of obesity in children and young adults. N Engl J Med. 2015;373:1307–17.PubMed
7.
go back to reference Ward ZJ, Long MW, Resch SC, Giles CM, Cradock AL, Gortmaker SL. Simulation of growth trajectories of childhood obesity into adulthood. N Engl J Med. 2017;377:2145–53.PubMedPubMedCentral Ward ZJ, Long MW, Resch SC, Giles CM, Cradock AL, Gortmaker SL. Simulation of growth trajectories of childhood obesity into adulthood. N Engl J Med. 2017;377:2145–53.PubMedPubMedCentral
8.
go back to reference Jacobs DR Jr, Woo JG, Sinaiko AR, Daniels SR, Ikonen J, Juonala M, Kartiosuo N, Lehtimaki T, Magnussen CG, Viikari JSA, et al. Childhood cardiovascular risk factors and adult cardiovascular events. N Engl J Med. 2022;386:1877–88.PubMedPubMedCentral Jacobs DR Jr, Woo JG, Sinaiko AR, Daniels SR, Ikonen J, Juonala M, Kartiosuo N, Lehtimaki T, Magnussen CG, Viikari JSA, et al. Childhood cardiovascular risk factors and adult cardiovascular events. N Engl J Med. 2022;386:1877–88.PubMedPubMedCentral
9.
go back to reference Wright CM, Cole TJ, Fewtrell M, Williams JE, Eaton S, Wells JC. Body composition data show that high BMI centiles overdiagnose obesity in children aged under 6 years. Am J Clin Nutr. 2022;116:122–31.PubMed Wright CM, Cole TJ, Fewtrell M, Williams JE, Eaton S, Wells JC. Body composition data show that high BMI centiles overdiagnose obesity in children aged under 6 years. Am J Clin Nutr. 2022;116:122–31.PubMed
10.
go back to reference Hampl SE, Hassink SG, Skinner AC, Armstrong SC, Barlow SE, Bolling CF, Avila Edwards KC, Eneli I, Hamre R, Joseph MM, et al. Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics. 2023;151:e2022060640.PubMed Hampl SE, Hassink SG, Skinner AC, Armstrong SC, Barlow SE, Bolling CF, Avila Edwards KC, Eneli I, Hamre R, Joseph MM, et al. Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics. 2023;151:e2022060640.PubMed
11.
go back to reference Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320:1240–3.PubMedPubMedCentral Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320:1240–3.PubMedPubMedCentral
12.
go back to reference Gómez-Ambrosi J, Silva C, Galofré JC, Escalada J, Santos S, Millán D, Vila N, Ibañez P, Gil MJ, Valentí V, et al. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes. 2012;36:286–94. Gómez-Ambrosi J, Silva C, Galofré JC, Escalada J, Santos S, Millán D, Vila N, Ibañez P, Gil MJ, Valentí V, et al. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes. 2012;36:286–94.
13.
go back to reference Javed A, Jumean M, Murad MH, Okorodudu D, Kumar S, Somers VK, Sochor O, Lopez-Jimenez F. Diagnostic performance of body mass index to identify obesity as defined by body adiposity in children and adolescents: a systematic review and meta-analysis. Pediatr Obes. 2015;10:234–44.PubMed Javed A, Jumean M, Murad MH, Okorodudu D, Kumar S, Somers VK, Sochor O, Lopez-Jimenez F. Diagnostic performance of body mass index to identify obesity as defined by body adiposity in children and adolescents: a systematic review and meta-analysis. Pediatr Obes. 2015;10:234–44.PubMed
14.
go back to reference Williams DP, Going SB, Lohman TG, Harsha DW, Srinivasan SR, Webber LS, Berenson GS. Body fatness and risk for elevated blood pressure, total cholesterol, and serum lipoprotein ratios in children and adolescents. Am J Public Health. 1992;82:358–63.PubMedPubMedCentral Williams DP, Going SB, Lohman TG, Harsha DW, Srinivasan SR, Webber LS, Berenson GS. Body fatness and risk for elevated blood pressure, total cholesterol, and serum lipoprotein ratios in children and adolescents. Am J Public Health. 1992;82:358–63.PubMedPubMedCentral
15.
go back to reference Dangardt F, Charakida M, Georgiopoulos G, Chiesa ST, Rapala A, Wade KH, Hughes AD, Timpson NJ, Pateras K, Finer N, et al. Association between fat mass through adolescence and arterial stiffness: a population-based study from the Avon Longitudinal Study of parents and children. Lancet Child Adolesc Health. 2019;3:474–81.PubMedPubMedCentral Dangardt F, Charakida M, Georgiopoulos G, Chiesa ST, Rapala A, Wade KH, Hughes AD, Timpson NJ, Pateras K, Finer N, et al. Association between fat mass through adolescence and arterial stiffness: a population-based study from the Avon Longitudinal Study of parents and children. Lancet Child Adolesc Health. 2019;3:474–81.PubMedPubMedCentral
16.
go back to reference Gómez-Ambrosi J, Silva C, Galofré JC, Escalada J, Santos S, Gil MJ, Valentí V, Rotellar F, Ramírez B, Salvador J, et al. Body adiposity and type 2 diabetes: increased risk with a high body fat percentage even having a normal BMI. Obesity. 2011;19:1439–44.PubMed Gómez-Ambrosi J, Silva C, Galofré JC, Escalada J, Santos S, Gil MJ, Valentí V, Rotellar F, Ramírez B, Salvador J, et al. Body adiposity and type 2 diabetes: increased risk with a high body fat percentage even having a normal BMI. Obesity. 2011;19:1439–44.PubMed
17.
go back to reference Flegal KM, Graubard BI. Estimates of excess deaths associated with body mass index and other anthropometric variables. Am J Clin Nutr. 2009;89:1213–9.PubMedPubMedCentral Flegal KM, Graubard BI. Estimates of excess deaths associated with body mass index and other anthropometric variables. Am J Clin Nutr. 2009;89:1213–9.PubMedPubMedCentral
18.
go back to reference Azcona C, Köek N, Frühbeck G. Fat mass by air-displacement plethysmography and impedance in obese/non-obese children and adolescents. Int J Pediatr Obes. 2006;1:176–82.PubMed Azcona C, Köek N, Frühbeck G. Fat mass by air-displacement plethysmography and impedance in obese/non-obese children and adolescents. Int J Pediatr Obes. 2006;1:176–82.PubMed
19.
go back to reference Gómez-Ambrosi J, Azcona C, Patiño-García A, Frühbeck G. Serum amyloid A concentration is increased in obese children and adolescents. J Pediatr. 2008;153:71–5.PubMed Gómez-Ambrosi J, Azcona C, Patiño-García A, Frühbeck G. Serum amyloid A concentration is increased in obese children and adolescents. J Pediatr. 2008;153:71–5.PubMed
20.
go back to reference Zapata JK, Catalán V, Rodríguez A, Ramírez B, Silva C, Escalada J, Salvador J, Calamita G, Azcona-Sanjulian MC, Frühbeck G, et al. Resting energy expenditure is not altered in children and adolescents with obesity. Effect of age and gender and association with serum leptin levels. Nutrients. 2021;13:1216.PubMedPubMedCentral Zapata JK, Catalán V, Rodríguez A, Ramírez B, Silva C, Escalada J, Salvador J, Calamita G, Azcona-Sanjulian MC, Frühbeck G, et al. Resting energy expenditure is not altered in children and adolescents with obesity. Effect of age and gender and association with serum leptin levels. Nutrients. 2021;13:1216.PubMedPubMedCentral
21.
go back to reference Berenbaum SA, Beltz AM, Corley R. The importance of puberty for adolescent development: conceptualization and measurement. Adv Child Dev Behav. 2015;48:53–92.PubMed Berenbaum SA, Beltz AM, Corley R. The importance of puberty for adolescent development: conceptualization and measurement. Adv Child Dev Behav. 2015;48:53–92.PubMed
22.
go back to reference Fields DA, Goran MI, McCrory MA. Body-composition assessment via air-displacement plethysmography in adults and children: a review. Am J Clin Nutr. 2002;75:453–67.PubMed Fields DA, Goran MI, McCrory MA. Body-composition assessment via air-displacement plethysmography in adults and children: a review. Am J Clin Nutr. 2002;75:453–67.PubMed
23.
go back to reference Gutierrez-Marin D, Escribano J, Closa-Monasterolo R, Ferre N, Venables M, Singh P, Wells JC, Munoz-Hernando J, Zaragoza-Jordana M, Gispert-Llaurado M, et al. Validation of bioelectrical impedance analysis for body composition assessment in children with obesity aged 8-14y. Clin Nutr. 2021;40:4132–9.PubMed Gutierrez-Marin D, Escribano J, Closa-Monasterolo R, Ferre N, Venables M, Singh P, Wells JC, Munoz-Hernando J, Zaragoza-Jordana M, Gispert-Llaurado M, et al. Validation of bioelectrical impedance analysis for body composition assessment in children with obesity aged 8-14y. Clin Nutr. 2021;40:4132–9.PubMed
24.
go back to reference Taylor RW, Falorni A, Jones IE, Goulding A. Identifying adolescents with high percentage body fat: a comparison of BMI cutoffs using age and stage of pubertal development compared with BMI cutoffs using age alone. Eur J Clin Nutr. 2003;57:764–9.PubMed Taylor RW, Falorni A, Jones IE, Goulding A. Identifying adolescents with high percentage body fat: a comparison of BMI cutoffs using age and stage of pubertal development compared with BMI cutoffs using age alone. Eur J Clin Nutr. 2003;57:764–9.PubMed
25.
go back to reference McCarthy HD, Cole TJ, Fry T, Jebb SA, Prentice AM. Body fat reference curves for children. Int J Obes (Lond). 2006;30:598–602.PubMed McCarthy HD, Cole TJ, Fry T, Jebb SA, Prentice AM. Body fat reference curves for children. Int J Obes (Lond). 2006;30:598–602.PubMed
27.
go back to reference Gómez-Ambrosi J, Catalán V, Rodríguez A, Andrada P, Ramírez B, Ibañez P, Vila N, Romero S, Margall MA, Gil MJ, et al. Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy. Diabetes Care. 2014;37:2813–20.PubMed Gómez-Ambrosi J, Catalán V, Rodríguez A, Andrada P, Ramírez B, Ibañez P, Vila N, Romero S, Margall MA, Gil MJ, et al. Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy. Diabetes Care. 2014;37:2813–20.PubMed
28.
go back to reference Frühbeck G, Gómez-Ambrosi J. Control of body weight: a physiologic and transgenic perspective. Diabetologia. 2003;46:143–72.PubMed Frühbeck G, Gómez-Ambrosi J. Control of body weight: a physiologic and transgenic perspective. Diabetologia. 2003;46:143–72.PubMed
29.
30.
go back to reference Kim JY, Bacha F, Tfayli H, Michaliszyn SF, Yousuf S, Arslanian S. Adipose tissue insulin resistance in youth on the spectrum from normal weight to obese and from normal glucose tolerance to impaired glucose tolerance to type 2 diabetes. Diabetes Care. 2019;42:265–72.PubMed Kim JY, Bacha F, Tfayli H, Michaliszyn SF, Yousuf S, Arslanian S. Adipose tissue insulin resistance in youth on the spectrum from normal weight to obese and from normal glucose tolerance to impaired glucose tolerance to type 2 diabetes. Diabetes Care. 2019;42:265–72.PubMed
31.
go back to reference Jebeile H, Kelly AS, O’Malley G, Baur LA. Obesity in children and adolescents: epidemiology, causes, assessment, and management. Lancet Diabetes Endocrinol. 2022;10:351–65.PubMedPubMedCentral Jebeile H, Kelly AS, O’Malley G, Baur LA. Obesity in children and adolescents: epidemiology, causes, assessment, and management. Lancet Diabetes Endocrinol. 2022;10:351–65.PubMedPubMedCentral
32.
go back to reference Cypess AM. Reassessing human adipose tissue. N Engl J Med. 2022;386:768–79.PubMed Cypess AM. Reassessing human adipose tissue. N Engl J Med. 2022;386:768–79.PubMed
33.
go back to reference Simmonds M, Llewellyn A, Owen CG, Woolacott N. Simple tests for the diagnosis of childhood obesity: a systematic review and meta-analysis. Obes Rev. 2016;17:1301–15.PubMed Simmonds M, Llewellyn A, Owen CG, Woolacott N. Simple tests for the diagnosis of childhood obesity: a systematic review and meta-analysis. Obes Rev. 2016;17:1301–15.PubMed
34.
go back to reference Ryder JR, Kaizer AM, Rudser KD, Daniels SR, Kelly AS. Utility of body mass index in identifying excess adiposity in youth across the obesity spectrum. J Pediatr. 2016;177:255–61.PubMedPubMedCentral Ryder JR, Kaizer AM, Rudser KD, Daniels SR, Kelly AS. Utility of body mass index in identifying excess adiposity in youth across the obesity spectrum. J Pediatr. 2016;177:255–61.PubMedPubMedCentral
35.
go back to reference Heymsfield SB, Wadden TA. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376:254–66.PubMed Heymsfield SB, Wadden TA. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376:254–66.PubMed
36.
go back to reference Segal KR, Dunaif A, Gutin B, Albu J, Nyman A, Pi-Sunyer FX. Body composition, not body weight, is related to cardiovascular disease risk factors and sex hormone levels in men. J Clin Invest. 1987;80:1050–5.PubMedPubMedCentral Segal KR, Dunaif A, Gutin B, Albu J, Nyman A, Pi-Sunyer FX. Body composition, not body weight, is related to cardiovascular disease risk factors and sex hormone levels in men. J Clin Invest. 1987;80:1050–5.PubMedPubMedCentral
38.
go back to reference Van Hulst A, Ybarra M, Mathieu ME, Benedetti A, Paradis G, Henderson M. Determinants of new onset cardiometabolic risk among normal weight children. Int J Obes (Lond). 2020;44:781–9.PubMed Van Hulst A, Ybarra M, Mathieu ME, Benedetti A, Paradis G, Henderson M. Determinants of new onset cardiometabolic risk among normal weight children. Int J Obes (Lond). 2020;44:781–9.PubMed
39.
go back to reference Viitasalo A, Schnurr TM, Pitkanen N, Hollensted M, Nielsen TRH, Pahkala K, Atalay M, Lind MV, Heikkinen S, Frithioff-Bojsoe C, et al. Abdominal adiposity and cardiometabolic risk factors in children and adolescents: a mendelian randomization analysis. Am J Clin Nutr. 2019;110:1079–87.PubMedPubMedCentral Viitasalo A, Schnurr TM, Pitkanen N, Hollensted M, Nielsen TRH, Pahkala K, Atalay M, Lind MV, Heikkinen S, Frithioff-Bojsoe C, et al. Abdominal adiposity and cardiometabolic risk factors in children and adolescents: a mendelian randomization analysis. Am J Clin Nutr. 2019;110:1079–87.PubMedPubMedCentral
40.
go back to reference Raheem J, Sliz E, Shin J, Holmes MV, Pike GB, Richer L, Gaudet D, Paus T, Pausova Z. Visceral adiposity is associated with metabolic profiles predictive of type 2 diabetes and myocardial infarction. Commun Med (Lond). 2022;2:81.PubMed Raheem J, Sliz E, Shin J, Holmes MV, Pike GB, Richer L, Gaudet D, Paus T, Pausova Z. Visceral adiposity is associated with metabolic profiles predictive of type 2 diabetes and myocardial infarction. Commun Med (Lond). 2022;2:81.PubMed
41.
go back to reference Jin B, Lin H, Yuan J, Dong G, Huang K, Wu W, Chen X, Zhang L, Wang J, Liang X, et al. Abdominal adiposity and total body fat as predictors of cardiometabolic health in children and adolescents with obesity. Front Endocrinol (Lausanne). 2020;11:579.PubMed Jin B, Lin H, Yuan J, Dong G, Huang K, Wu W, Chen X, Zhang L, Wang J, Liang X, et al. Abdominal adiposity and total body fat as predictors of cardiometabolic health in children and adolescents with obesity. Front Endocrinol (Lausanne). 2020;11:579.PubMed
42.
go back to reference Hetherington-Rauth M, Bea JW, Lee VR, Blew RM, Funk JL, Lohman TG, Going SB. Relationship between fat distribution and cardiometabolic risk in hispanic girls. Am J Hum Biol. 2018;30:e23149.PubMedPubMedCentral Hetherington-Rauth M, Bea JW, Lee VR, Blew RM, Funk JL, Lohman TG, Going SB. Relationship between fat distribution and cardiometabolic risk in hispanic girls. Am J Hum Biol. 2018;30:e23149.PubMedPubMedCentral
43.
go back to reference Fu L, Cheng H, Zhao X, Hou D, Xie X, Mi J. Distinct causal effects of body fat distribution on cardiometabolic traits among children: findings from the BCAMS study. Nutr Metab Cardiovasc Dis. 2022;32:1753–65.PubMed Fu L, Cheng H, Zhao X, Hou D, Xie X, Mi J. Distinct causal effects of body fat distribution on cardiometabolic traits among children: findings from the BCAMS study. Nutr Metab Cardiovasc Dis. 2022;32:1753–65.PubMed
44.
go back to reference Yan Y, Liu J, Zhao X, Cheng H, Huang G, Mi J, China CACHSR. Group: Regional adipose compartments confer different cardiometabolic risk in children and adolescents: The China Child and Adolescent Cardiovascular Health Study. Mayo Clin Proc. 2019;94:1974-82. Yan Y, Liu J, Zhao X, Cheng H, Huang G, Mi J, China CACHSR. Group: Regional adipose compartments confer different cardiometabolic risk in children and adolescents: The China Child and Adolescent Cardiovascular Health Study. Mayo Clin Proc. 2019;94:1974-82.
45.
go back to reference Frühbeck G, Kiortsis DN, Catalán V. Precision medicine: diagnosis and management of obesity. Lancet Diabetes Endocrinol. 2018;6:164–6.PubMed Frühbeck G, Kiortsis DN, Catalán V. Precision medicine: diagnosis and management of obesity. Lancet Diabetes Endocrinol. 2018;6:164–6.PubMed
46.
go back to reference WHO Expert Consultation. Appropriate body-mass index for asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63. WHO Expert Consultation. Appropriate body-mass index for asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63.
47.
go back to reference Barlow SE, Expert C. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007;120(Suppl 4):164–92. Barlow SE, Expert C. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007;120(Suppl 4):164–92.
48.
go back to reference Kartiosuo N, Ramakrishnan R, Lemeshow S, Juonala M, Burns TL, Woo JG, Jacobs DR Jr, Daniels SR, Venn A, Steinberger J, et al. Predicting overweight and obesity in young adulthood from childhood body-mass index: comparison of cutoffs derived from longitudinal and cross-sectional data. Lancet Child Adolesc Health. 2019;3:795–802.PubMedPubMedCentral Kartiosuo N, Ramakrishnan R, Lemeshow S, Juonala M, Burns TL, Woo JG, Jacobs DR Jr, Daniels SR, Venn A, Steinberger J, et al. Predicting overweight and obesity in young adulthood from childhood body-mass index: comparison of cutoffs derived from longitudinal and cross-sectional data. Lancet Child Adolesc Health. 2019;3:795–802.PubMedPubMedCentral
Metadata
Title
BMI-based obesity classification misses children and adolescents with raised cardiometabolic risk due to increased adiposity
Authors
J. Karina Zapata
M. Cristina Azcona-Sanjulian
Victoria Catalán
Beatriz Ramírez
Camilo Silva
Amaia Rodríguez
Javier Escalada
Gema Frühbeck
Javier Gómez-Ambrosi
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2023
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/s12933-023-01972-8

Other articles of this Issue 1/2023

Cardiovascular Diabetology 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine